Zurich Insurance Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.25M | Hold |
7,700
| – | – | 0.02% | 270 |
|
|
2025
Q4 | $2.7M | Buy |
+7,700
| New | +$2.6M | 0.02% | 212 |
|
|
2025
Q1 | – | Sell |
-4,000
| Closed | -$1.48M | – | 275 |
|
|
2024
Q4 | $1.48M | Hold |
4,000
| – | – | 0.01% | 202 |
|
|
2024
Q3 | $2.08M | Hold |
4,000
| – | – | 0.02% | 155 |
|
|
2024
Q2 | $2.17M | Hold |
4,000
| – | – | 0.02% | 150 |
|
|
2024
Q1 | $2.07M | Hold |
4,000
| – | – | 0.02% | 170 |
|
|
2023
Q4 | $1.89M | Hold |
4,000
| – | – | 0.02% | 176 |
|
|
2023
Q3 | $1.74M | Hold |
4,000
| – | – | 0.02% | 173 |
|
|
2023
Q2 | $1.78M | Hold |
4,000
| – | – | 0.02% | 154 |
|
|
2023
Q1 | $1.84M | Hold |
4,000
| – | – | 0.02% | 147 |
|
|
2022
Q4 | $2.05M | Hold |
4,000
| – | – | 0.03% | 126 |
|
|
2022
Q3 | $1.82M | Hold |
4,000
| – | – | 0.03% | 127 |
|
|
2022
Q2 | $1.93M | Hold |
4,000
| – | – | 0.03% | 138 |
|
|
2022
Q1 | $1.97M | Hold |
4,000
| – | – | 0.02% | 127 |
|
|
2021
Q4 | $1.85M | Buy |
+4,000
| New | +$1.68M | 0.02% | 131 |
|
|
2021
Q3 | – | Sell |
-4,400
| Closed | -$1.68M | – | 225 |
|
|
2021
Q2 | $1.68M | Sell |
4,400
-1,200
| -21% | -$459K | 0.02% | 151 |
|
|
2021
Q1 | $2.01M | Buy |
+5,600
| New | +$1.8M | 0.03% | 115 |
|
|
2019
Q4 | – | Sell |
-44,000
| Closed | -$10.6M | – | 311 |
|
|
2019
Q3 | $10.6M | Buy |
44,000
+1,456
| +3% | +$399K | 0.2% | 126 |
|
|
2019
Q2 | $12M | Buy |
42,544
+1,667
| +4% | +$455K | 0.24% | 115 |
|
|
2019
Q1 | $11.7M | Sell |
40,877
-18,764
| -31% | -$5.43M | 0.25% | 122 |
|
|
2018
Q4 | $15.7M | Sell |
59,641
-51,130
| -46% | -$14.1M | 0.38% | 79 |
|
|
2018
Q3 | $30.4M | Buy |
110,771
+50,304
| +83% | +$13.1M | 0.64% | 34 |
|
|
2018
Q2 | $14.4M | Buy |
60,467
+20,217
| +50% | +$4.68M | 0.33% | 79 |
|
|
2018
Q1 | $8.84M | Sell |
40,250
-16,972
| -30% | -$3.99M | 0.2% | 133 |
|
|
2017
Q4 | $12.9M | Sell |
57,222
-1,371
| -2% | -$292K | 0.3% | 74 |
|
|
2017
Q3 | $11.1M | Buy |
58,593
+18,303
| +45% | +$3.48M | 0.3% | 76 |
|
|
2017
Q2 | $7.58M | Sell |
40,290
-950
| -2% | -$171K | 0.21% | 109 |
|
|
2017
Q1 | $6.82M | Buy |
41,240
+497
| +1% | +$79.1K | 0.2% | 117 |
|
|
2016
Q4 | $5.86M | Buy |
40,743
+15,384
| +61% | +$2.06M | 0.19% | 133 |
|
|
2016
Q3 | $3.18M | Sell |
25,359
-10,265
| -29% | -$1.33M | 0.11% | 231 |
|
|
2016
Q2 | $4.68M | Buy |
35,624
+604
| +2% | +$82.6K | 0.16% | 160 |
|
|
2016
Q1 | $4.87M | Buy |
+35,020
| New | +$4.68M | 0.17% | 159 |
|
Other funds holding ELV
VCM
VPM
Zurich Insurance Group's ELV Position: Q1 2026 in Review
Zurich Insurance Group held its Elevance Health (ELV) position steady in Q1 2026 at 7,700 shares worth $2.25M. The position accounts for 0.02% of the portfolio, ranked #270.
Zurich Insurance Group first reported a position in ELV in Q1 2016 and has held it in 32 quarters since. The position peaked at $30.4M in Q3 2018. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Zurich Insurance Group held 7,700 shares of Elevance Health worth $2.25M as of Q1 2026.
- Zurich Insurance Group left its Elevance Health share count unchanged in Q1 2026.
- Elevance Health made up 0.02% of Zurich Insurance Group's portfolio in Q1 2026, its #270 holding.
- Zurich Insurance Group first reported a position in Elevance Health in Q1 2016 and has held it in 32 quarters since.
- Zurich Insurance Group's Elevance Health position peaked at $30.4M in Q3 2018.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.